Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2013
10/01/2013US8545886 Extended release tablet formulations of flibanserin and method for manufacturing the same
10/01/2013CA2719876C Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/01/2013CA2710959C Imidazole carbonyl compounds and use thereof for treating bacterial infections
10/01/2013CA2694242C Process for introduction of hydroxyethoxy side chain in bosentan
10/01/2013CA2619010C Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
10/01/2013CA2565568C Pyrimidines as plk inhibitors
10/01/2013CA2532152C Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
10/01/2013CA2506826C Uracils having a herbicidal activity
09/2013
09/26/2013WO2013142307A1 Carbamate compounds and of making and using same
09/26/2013WO2013142266A1 Estrogen receptor modulators and uses thereof
09/26/2013WO2013141014A1 Novel compound and photosensitive resin composition
09/26/2013WO2013140347A1 Sulphonamide derivatives of benzylamine for the treatment of cns diseases
09/26/2013WO2013140232A1 An improved process for the preparation of sunitinib and its acid addition salts thereof
09/26/2013WO2013139799A1 Isoindolo[2,1-a]quinazoline derivatives for stabilization of organic materials
09/26/2013WO2013139760A1 Herbicidal compounds
09/26/2013US20130253186 Heteroaryloxyheterocyclyl compounds as pde10 inhibitors
09/26/2013US20130253024 Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents
09/26/2013US20130253008 Substituted azoles, antiviral active component, pharmaceutical composition, method for preparation and use thereof
09/26/2013US20130253004 Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis
09/26/2013US20130252986 Compounds
09/26/2013US20130252981 Pyrimidine compound and use thereof for pest control
09/26/2013US20130252963 Pyrimidinone compounds for use in the treatment of disease or conditions mediated by lp-pla2
09/26/2013US20130252942 Quinazoline carboxamide azetidines
09/25/2013EP2640806A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/25/2013EP2640726A1 Novel compound for organic electronic material and organic electroluminescent device using the same
09/25/2013EP2640719A2 Antiviral compounds
09/25/2013EP2640718A1 Substituted sodium-1h-pyrazole-5-olate
09/25/2013EP2640716A1 Cyclic amide compounds and their use in the treatment of disease
09/25/2013EP2640709A2 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
09/25/2013EP2640698A1 Nampt and rock inhibitors
09/25/2013CN103328466A Novel specific HCV NS3 protease inhibitors
09/25/2013CN103328465A Processes for the preparation of 3-(pyrrol-2-yl)methylene)-2-pyrrolones using 2-silyloxy-pyrroles
09/25/2013CN103328446A Novel 4-amino-n-hydroxy-benzamides for the treatment of cancer
09/25/2013CN103328445A Improved process for preparation of low molecular weight molybdenum succinimide complexes
09/25/2013CN103328442A Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases
09/25/2013CN103319464A 病毒聚合酶抑制剂 Viral polymerase inhibitors
09/25/2013CN103319463A N1-substituted 3,4-dihydropyrimidine-2-ketone-C60 compound and preparation method thereof
09/25/2013CN103319462A Preparation method of halosulfuron methyl
09/25/2013CN103319461A Preparation method of olmesartan medoxomil intermediate and synthesis method of olmesartan medoxomil
09/25/2013CN103319460A Ionic liquid-loaded diol containing cyano anions and application thereof in Heck reaction
09/25/2013CN102558158B Hairpin polyamide modified by or free of beta-hydroxyl-gamma-amino acid and preparation method and application
09/25/2013CN101798300B N-phenylindole methyl substituted bis-benzimidazole derivative and application thereof in reducing blood pressure and the like
09/25/2013CN101535299B 5-lipoxygenase-activating protein (flap) inhibitors
09/24/2013US8541579 Substituted diketopiperazines as oxytocin antagonists
09/24/2013US8541572 Compounds for the treatment of inflammatory disorders
09/24/2013US8541433 Combination comprising macitentan and paclitaxel for treating multi-drug resistant ovarian cancer
09/24/2013US8541420 Ketolide compounds having antimicrobial activity
09/24/2013US8541414 Pyridazinone compound and use thereof as herbicides
09/24/2013US8541113 Pyrene compounds and organic electroluminescent devices using the same
09/24/2013CA2608184C N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
09/24/2013CA2592345C Piperidine and azetidine derivatives as glyt1 inhibitors
09/24/2013CA2545425C Azole-based kinase inhibitors
09/24/2013CA2474277C 2,4-pyrimidinediamine compounds and their uses
09/19/2013WO2013138617A1 3,5-diaminopyrazole kinase inhibitors
09/19/2013WO2013138613A1 3,5-diaminopyrazole kinase inhibitors
09/19/2013WO2013137441A1 Oral pharmaceutical composition
09/19/2013WO2013135870A1 Process for the synthesis of telaprevir, or pharmaceutically acceptable salts or solvates as well as intermediate products thereof
09/19/2013WO2013135671A1 Fungicidal pyrimidine compounds
09/19/2013WO2013102929A4 Novel compounds for treatment of diabetes, obesity or related disorders
09/19/2013US20130245262 Process for the preparation of pazopanib using novel intermediate
09/19/2013US20130245259 Process for the preparation of bosentan monohydrate
09/19/2013US20130245041 Dual-acting pyrazole antihypertensive agents
09/19/2013US20130245034 Inhibitors Of Histone Deacetylase
09/19/2013US20130245033 Amide compounds
09/19/2013US20130245015 Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
09/19/2013US20130244994 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
09/19/2013US20130244958 Substituted pyrrolidine-2-carboxamides
09/19/2013US20130243754 Heterocyclic compounds and methods of use
09/19/2013US20130241400 Secondary hole transporting layer with tricarbazole compounds
09/18/2013EP2639226A1 Anti-infective pyrimidines and uses thereof
09/18/2013EP2638180A1 Non metal tanning
09/18/2013EP2638036A1 Compound for increasing kinase active and application thereof
09/18/2013EP2638035A1 Triazole derivatives as ligands for gaba receptors
09/18/2013EP2638034A1 Substituted heteroaromatic carboxamide and urea derivatives as vanilloid receptor ligands
09/18/2013EP2638031A1 Pyrazole aminopyrimidine derivatives as lrrk2 modulators
09/18/2013EP2638029A1 Triazole derivatives and their use for neurological disorders
09/18/2013EP2638018A1 Pyridine compounds and aza analogues thereof as tyk2 inhibitors
09/18/2013EP2638015A1 Substituted bicyclic carboxamide and urea derivatives as vanilloid receptor ligands
09/18/2013EP2637659A1 Sgc stimulators
09/18/2013EP2637502A1 Mutant-selective egfr inhibitors and uses thereof
09/18/2013CN103313979A Novel compound for organic electronic material and organic electroluminescent device using the same
09/18/2013CN103313978A Pyrazole aminopyrimidine derivatives as LRRK2 modulators
09/18/2013CN103313970A Novel bicyclic compound or salt thereof
09/18/2013CN103313968A Nampt and rock inhibitors
09/18/2013CN103305212A Wavelength-adjustable diarylethenyl quinoxalinyl pyridazinone organic luminescent material and preparation method thereof
09/18/2013CN103304543A Preparation method of candesartan cilexetil
09/18/2013CN103304541A Viral polymerase inhibitors
09/18/2013CN102603619B Compound with anticancer activity and preparation method thereof
09/18/2013CN102482511B Aqueous pigment dispersion and aqueous ink for inkjet recording
09/18/2013CN102295640B 3-heterocycle schiff base-5-fluorine-indole-2-ketone compounds, preparation method thereof and application thereof
09/18/2013CN102060848B Preparation and application of aromatic amine substituted pyrimidine derivatives
09/18/2013CN102006873B Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor
09/18/2013CN101878199B 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis
09/18/2013CN101495472B Fungicide N-cycloalkyl-carboxamide derivatives
09/17/2013US8536375 Synthesis of obtaining modified polyethylene glycol intermediates
09/17/2013US8536329 Reactive dye
09/17/2013US8536180 Pyrimidine inhibitors of kinase activity
09/17/2013US8536177 Therapeutic agents useful for treating pain
09/17/2013US8536169 Compounds
09/17/2013US8536092 Anthranilic acid diamide derivative with hetero-aromatic and hetero-cyclic substituents
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 626